AU6507996A - Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells - Google Patents

Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells

Info

Publication number
AU6507996A
AU6507996A AU65079/96A AU6507996A AU6507996A AU 6507996 A AU6507996 A AU 6507996A AU 65079/96 A AU65079/96 A AU 65079/96A AU 6507996 A AU6507996 A AU 6507996A AU 6507996 A AU6507996 A AU 6507996A
Authority
AU
Australia
Prior art keywords
estrogen
medicament
cells
manufacture
phenol compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65079/96A
Inventor
Katherine Gordon
Pattie S. Green
James W. Simpkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of AU6507996A publication Critical patent/AU6507996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
AU65079/96A 1995-07-24 1996-07-24 Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells Abandoned AU6507996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US139495P 1995-07-24 1995-07-24
US001394 1995-07-24
PCT/US1996/012146 WO1997003661A1 (en) 1995-07-24 1996-07-24 Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells

Publications (1)

Publication Number Publication Date
AU6507996A true AU6507996A (en) 1997-02-18

Family

ID=21695818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65079/96A Abandoned AU6507996A (en) 1995-07-24 1996-07-24 Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells

Country Status (5)

Country Link
EP (1) EP0841906A1 (en)
JP (1) JPH11510144A (en)
AU (1) AU6507996A (en)
CA (1) CA2227634A1 (en)
WO (1) WO1997003661A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL342313A1 (en) * 1998-02-20 2001-06-04 Jenapharm Gmbh Pharmacological preparations for selectively supplementing deficiency of oestrogens in the central nervous system
US6245756B1 (en) 1998-02-27 2001-06-12 Jenapharm Gmbh & Co. Kg Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system
US6472436B1 (en) * 2000-07-17 2002-10-29 The Salk Institute For Biological Studies Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
US20020025953A1 (en) * 2000-08-17 2002-02-28 Gordon Katherine D. Novel formulations for administering therapeutic lipophilic molecules
ES2287184T3 (en) 2000-11-03 2007-12-16 Washington University AROMATIC STRUCTURES MODIFIED WITH HYDROXY- SUBSTITUTES, WHICH HAVE CITOPROTECTING ACTIVITY.
WO2002040032A2 (en) * 2000-11-17 2002-05-23 Washington University Cytoprotective estrogen derivatives
US11969351B2 (en) 2022-02-03 2024-04-30 James M. Jackson Systems and methods for magnetic joints

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803582A1 (en) * 1978-01-27 1979-08-02 Sandoz Ag 2-Amino-tetra:hydro-naphthol derivs. - used as adrenergic and dopamine receptor stimulants useful for treating heart failure, cardiac infarct, hypertension and Parkinsonism
WO1987002666A2 (en) * 1985-10-31 1987-05-07 Maggioni-Winthrop S.P.A. Bicyclic alkoxy- and alkylthio-substituted aminoalcohols
DK231088D0 (en) * 1988-04-28 1988-04-28 Ferrosan As PIPERIDE CONNECTIONS, THEIR PREPARATION AND USE
DE69124380T2 (en) * 1990-08-23 1997-08-14 Univ New York METHOD AND COMPOSITIONS FOR THE TREATMENT BY T-CELL-MEDIATED DISEASES
US5141934A (en) * 1990-10-30 1992-08-25 Warner-Lambert Company Tetracyclic amines having pharmaceutical activity
CA2111138A1 (en) * 1993-01-15 1994-07-16 Thierry Godel Octahydrophenanthrene derivatives
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease

Also Published As

Publication number Publication date
WO1997003661A1 (en) 1997-02-06
CA2227634A1 (en) 1997-02-06
EP0841906A1 (en) 1998-05-20
JPH11510144A (en) 1999-09-07

Similar Documents

Publication Publication Date Title
EP0694552A3 (en) The preparation of sulfur-containing organosilicon compounds
AU6113994A (en) Improvements relating to foot orthoses
EP0705838A3 (en) Process for the preparation of silane polysulfides
EP0711559A3 (en) Use of phosphatidylserines for the manufacture of a medicament for improving cerebration
AU5086093A (en) Process for the preparation of etbe
AU3236895A (en) Aspb1 insulin analogs
AU6745696A (en) The preparation of fluorinated organic compounds
AU2734895A (en) Process for the preparation of 3-aryluracils
AU1230595A (en) Process for the preparation of polyalkyl-1-oxa- diazaspirodecane compounds
AU4260196A (en) Fungicidal mixture
AU6507996A (en) Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells
AU7994694A (en) Controlled release oral delivery system containing oxybutynin
AU4534596A (en) Compounds with growth hormone releasing properties
AU3810495A (en) Process for the manufacture of n-phosphonomethylglycine
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU5095093A (en) Process for the preparation of tetrazoles
AU3574793A (en) Remedy for airway diseases
AU1142192A (en) Process for the preparation of 13c-labelled compounds
AU8457591A (en) Process for the preparation of carbapenem compounds
AU8535698A (en) A process for the preparation of diacerein
AU4588593A (en) Process for the preparation of a polymer composition
AU7894391A (en) Improvements relating to the manufacture of sheet material
AU2897695A (en) Insecticidal polycyclic compounds
AU3116695A (en) Tetracyclic triterpenes
AU6926894A (en) A process for the preparation of gemfibrozil